Compare CIGI & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIGI | MIR |
|---|---|---|
| Founded | 1972 | 2005 |
| Country | Canada | United States |
| Employees | N/A | 3281 |
| Industry | | Industrial Machinery/Components |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.6B |
| IPO Year | 1995 | N/A |
| Metric | CIGI | MIR |
|---|---|---|
| Price | $107.35 | $18.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $176.25 | $27.25 |
| AVG Volume (30 Days) | 332.8K | ★ 3.4M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.74 | $24.16 |
| Revenue Next Year | $8.04 | $7.31 |
| P/E Ratio | ★ $57.57 | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $95.66 | $12.00 |
| 52 Week High | $171.20 | $30.28 |
| Indicator | CIGI | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 44.54 |
| Support Level | $98.97 | N/A |
| Resistance Level | $121.40 | $22.23 |
| Average True Range (ATR) | 3.87 | 1.02 |
| MACD | 1.29 | 0.09 |
| Stochastic Oscillator | 76.62 | 65.73 |
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are Commercial Real Estate, Engineering and Investment Management. Maximum revenue for the company is generated from its Commercial Real Estate segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, and others. Geographically, the company generates maximum revenue from the United States followed by Canada, Euro currency countries, Australia, the United Kingdom, Poland, China, India, and other regions.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.